US 8541403
Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency
granted A61KA61K31/5025A61K31/5377
Quick answer
US patent 8541403 (Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOMARIN PHARMACEUTICAL INC.
- Grant date
- Tue Sep 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 38
- CPC classes
- A61K, A61K31/5025, A61K31/5377, A61K45/06, A61P